The haloperidol-induced increase of Fos-like immunoreactive (Fos-li) 
As detected by both immunocytochemistry and in situ hybridization, D 2 dopamine receptor antagonists reliably induced a marked increase of striatal Fos positive neurons (e.g. , Miller 1990; Dragunow et al. 1990; Nguyen et al. 1992; Robertson and Fibiger 1992; Deutch and Cameron 1992) . Presumably, this increase occurs in a subset of the striatal GABA neurons which are normally tonically inhibited via a D 2 receptor mechanism. The Fos response has been shown to have both predictive and construct validity for understanding the mechanisms of antipsychotic drug action. The data supporting this position may be briefly summarized: 1) Typical but not atypical antipsychotics increase the number of Fos positive neurons in the dorsolateral caudate-putamen (CPu) (Dragunow et al. 1990; Nguyen et al. 1992; Deutch and Cameron 1992; Robertson et al. 1994; Ishibashi et al. 1996) although olanzapine, a putative atypical antipsychotic, does show a Fos response similar to haloperidol (Robertson and Fibiger 1996) . Since the dorsolateral CPu has an important role in the regulation of movement (Pisa 1988; Carelli and West 1991) , these data suggest that the Fos response in the area may be predictive of the catalepsy response in rodents and extrapyramidal symptoms (EPS) in humans (Merchant and Dorsa 1993; Robertson et al. 1994; Robertson and Fibiger 1996) ; 2) Anticholinergic drugs e.g., scopolamine, which block the development of neuroleptic-induced EPS also block the Fos response (e.g., Guo et al. 1992 ); 3) All clinically effective antipsychotic drugs induce a Fos response in the nucleus accumbens (NAc), this being the only structure to date which consistently predicts therapeutic efficacy (Robertson et al. 1994; Deutch et al. 1996) ; and 4) Although most of the Fos data has been obtained in rodents, the Fos response in nonhuman primates appears similar (Deutch et al. 1996) .
To our knowledge the Fos strategy has not been applied to investigate the genetic variability in neuroleptic response. Among both inbred strains of mice and rats, there are marked differences in sensitivity for haloperidol-induced catalepsy (Kinon and Kane 1989; Kanes et al. 1993) . For example, among 40 standard and recombinant inbred mouse strains, the ED 50 for haloperidolinduced catalepsy varies more than 30 fold (Hitzemann et al. 1995 ) and these differences do not appear to be associated with differences in drug uptake or metabolism (Kanes et al. 1993) . Correlated traits to the catalepsy response include D 2 receptor density, the number of midbrain dopamine neurons, and the number of striatal cholinergic neurons (Qian et al. 1992 Kanes et al. 1993; Hitzemann et al. 1993 Hitzemann et al. , 1994 Dains et al. 1996) . Paradoxically, both somatodendritic and post-synaptic D 2 receptor density are increased in the non-responsive animals (Hitzemann et al. 1991; Qian et al. 1992 Qian et al. , 1993 Kanes et al. 1993 Kanes et al. , 1996 Cipp, 1995) . Quantitative trait loci (QTL) analysis of the catalepsy response has revealed three QTLs which map near three likely candidate genes, Drd2 , HTR2a , and Chat (Kanes et al. 1996; Rasmussen et al. 1997 ).
In the current study we have compared the Fos response to haloperidol in the C57BL/6J (B6) and DBA/2J (D2) inbred mouse strains. The ED 50s for haloperidol-induced catalepsy in the D2 and B6 strains are 0.4 and 3.8 mg/kg, respectively (Kanes et al. 1993) . In contrast, these strains are equally sensitive to the haloperidol facilitation of prepulse inhibition (PPI) of the acoustic startle response (McCaughran et al. 1997) , which is thought to reflect haloperidol's effects on the mesolimbic dopamine system (see e.g., Swerdlow et al. 1994) , although, there also appears to be some involvement of the caudodorsal striato-pallidal circuitry (Kodsi and Swerdlow, 1995) . Significant haloperidol effects on PPI are detected at 0.1 mg/kg. As a working hypothesis, we proposed that the Fos response to haloperidol in the D2 and B6 strains would parallel the results found for typical and atypical neuroleptics; in the dorsolateral CPu, the D2 strain would be more sensitive to the effects of haloperidol, whereas in the nucleus accumbens (NAc) the strains would be equally sensitive. The alternative hypothesis was that the strains would be equally sensitive to the effects of haloperidol in the CPu and the NAc, but would differ significantly at the output nuclei of the basal ganglia i.e., the entopeduncular nucleus (EP) and the substantia nigra zona reticulata (SNr). Wirtshafter and Asin (1995) have demonstrated that haloperidol causes a dose dependent increase of Fos-li neurons in both the EP and SNr and concluded that these data are consistent with the idea that receptor blockade results in disinhibition of cells in these brain regions.
METHODS

Animals
Male C57BL/6 and DBA/2J mice weighing 18-24 g were obtained from Jackson Laboratories (Bar Harbor, ME). Animals were housed under 12-hour light-dark cycle, fed food and water ab libitum , and acclimated to the new environment for at least two weeks. For the three days prior to testing, the animals were injected once daily intraperitoneally (i.p.) with saline. On testing day, the animals were randomly assigned to one of six groups-saline or haloperidol (0.1, 0.3, 1.0, 3.0, and 6.0 mg/kg). Haloperidol (Sigma Chemical Co., St. Louis, MO) was dissolved in saline with minimal amount of acetic acid, further diluted before injection and administered i.p. Sixty minutes after drug or saline treatment, the animals were deeply anesthetized with a 7:5 mixture of xylazine (8 mg/kg; Miles Inc, KN) and ketamine (60 mg/kg; Fort Dodge Laboratories, Fort Dodge, IW). The animals were transcardially perfused with 0.9% saline solution, the brains were removed and fixed overnight in 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH ϭ 7.4.
Immunohistochemistry
The paraformaldehyde fixed brains were transferred to ice-cold 30% sucrose in PB and were allowed to cryoprotect in this solution for 24-48 hours. Thirty-micrometer frozen coronal sections were cut on a microtome and collected in 10 mM phosphate buffered saline (PBS). The sections were rinsed three times in PBS and treated with 0.3% H 2 O 2 in PBS for fifteen minutes to block the endogenous peroxidase activity. The sections were rinsed in PBS six more times to remove the residual H 2 O 2 . The sections were then blocked for two hours in the immunoreaction buffer (10 mM PBS containing 0.25% Triton X-100 and 3% goat serum) without antibody; antibody (final dilution 1:20,000) was than added and the incubation was continued for 60 to 72 hrs at 4 Њ C. The antibody was obtained from Oncogene Science Inc. (Cambridge, MA); the antibody was raised against residues 4 -17 of human c-Fos protein.
The sections were rinsed three times in PBS and incu-bated with the biotinylated goat anti-rabbit IgG (1:200 of secondary antibody) in 10 mM PBS containing 0.3% Triton X-100 and 3% goat serum for two hours at room temperature. The sections were subsequently incubated with horseradish peroxidase avidin-biotin complex in 10 mM PBS for two hours at room temperature. The sections were rinsed three times in PBS and placed in 0.1 M Tris (pH 7.4) for 5 minutes. The chromatic reaction was accomplished with diaminobenzidine (50 mg/ 100 ml of 0.1 M Tris) in presence of 0.01% nickel ammonium sulfate solution and 0.035% hydrogen peroxide. The sections were mounted onto slides, dehydrated and cover-slipped with Permount.
Image Analysis
C-Fos positive nuclei were counted in seventeen regions of the basal ganglia ( Figure 1 ) using MCID M1 imaging software (St. Catharines, Ontario, CA). The target region was captured using a black and white digitizing camera. The targets were enhanced (against the background) using a matrix function. Targets with perimeter and area greater than 8 pixels were selected within the templates shown in the Figure 1 . The selected targets were manually examined for accuracy and incorrect selections were removed from the cell counts. Each region was counted at two rostral-caudal levels. The number of Fos-li neurons in a region were divided by the scan area to yield the number of Fos-li neurons within a 0.1 mm 2 area. 
Statistical Methods
The data were analyzed by standard analysis of variance techniques using Statistical software for Windows (Statsoft Inc., Tulsa, OK). Duncan's multiple range test was used for the post hoc analysis. Although multiple brain regions were examined, the Fos responses across regions and doses of haloperidol were highly correlated, thus reducing the number of independent tests. The number of such independent tests is clearly less than 102 (17 regions ϫ 6 treatment groups) but clearly more than 1. As a compromise, we have set the minimum threshold for a significant effect at p Ͻ 10 Ϫ 2
.
RESULTS
Experimental Design
Male D2 and B6 mice (N ϭ 8-12/group) were injected once daily with saline for three consecutive days. On day 4, the animals were administered either saline or haloperidol (0.1, 0.3, 1, 3, or 6 mg/kg). The ED 50s for haloperidol-induced catalepsy in the D2 and B6 strains are 0.4 and 3.8 mg/kg, respectively; at 6 mg/kg, all of the animals were cataleptic using the method for assessment described previously (Hitzemann et al. 1991; Kanes et al. 1993 ). The animals were sacrificed one hour later and the number of Fos-like immunoreactive (Fosli) neurons in the basal ganglia was determined as de- 2 Ϯ 1 4 Ϯ 1 9 Ϯ 2 10 Ϯ 2 26 Ϯ 5 34 Ϯ 3 28 Ϯ 3 37 Ϯ 5 36 Ϯ 3 39 Ϯ 3 29 Ϯ 2 28 Ϯ 5 Medial-EP 2 Ϯ 1 10 Ϯ 2 11 Ϯ 1 34 Ϯ 6 37 Ϯ 7 68 Ϯ 5 39 Ϯ 6 74 Ϯ 4 48 Ϯ 6 81 Ϯ 4 58 Ϯ 4 69 Ϯ 6 STh 13 Ϯ 6 10 Ϯ 2 12 Ϯ 4 15 Ϯ 2 15 Ϯ 7 16 Ϯ 5 13 Ϯ 4 8 Ϯ 2 15 Ϯ 4 27 Ϯ 10 7 Ϯ 2 11 Ϯ 2 Medial-SNr 1 Ϯ 1 2 Ϯ 1 3 Ϯ 1 3 Ϯ 1 9 Ϯ 5 11 Ϯ 2 10 Ϯ 2 29 Ϯ 3 20 Ϯ 2 37 Ϯ 3 29 Ϯ 4 34 Ϯ 3 Lateral-SNr
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b Abbreviations: nucleus accumbens (NAc); caudate-putamen (CPu); globus pallidus (GP); ventral pallidum (VP); subthalamic nucleus (STh); entopeduncular nucleus (EP); substantia nigra zona reticulata (SNr); substantia nigra zona compacta (SNc); ventral tegmental area (VTA). scribed in Methods. The one hour time course was chosen on the basis of pilot data which showed that the maximal Fos response is obtained 60-90 minutes after haloperidol administration; by three hours the response has significantly decreased. This observation of a rapid Fos response is consistent with the time-course found by others using various paradigms to stimulate Fos expression (e.g., Franza et al. 1987 Franza et al. , 1988 Sonnenberg et al. 1989; Dilts et al. 1993) . No significant differences were observed along the rostral-caudal axis within a given region (see Figure 1) , thus all data and statistical analysis presented here are based on the average of data taken from two rostral-caudal levels. Each region was analyzed independently. A tabular summary of the results are presented in Table 1 .
Caudate-Putamen
Four regions of the caudate-putamen (CPu) were examined: medial, dorsomedial, dorsolateral, and ventral lateral (Figure 1 ). For the dorsolateral CPu, the ANOVA revealed significant effects for treatment (F 5,297 ). For the ventrolateral CPu, the B6 strain showed a significantly greater increase in the number of Fos-li neurons at 3 mg/kg haloperidol (Figure 2 ). In the medial CPu, there was no significant strain ϫ treatment interaction (F 5,198 ϭ 2.1, p Ͻ 6 ϫ 10
Ϫ2
).
Nucleus Accumbens
The core of the nucleus accumbens (NAc) was divided into dorsal and medial aspects (Figure 1 ). Significant effects were detected for treatment (F 5,198 ϭ 15, p Ͻ 10
Ϫ5
) and region (F 1,198 ϭ 9.7, p Ͻ 10 Ϫ3 ) but not for strain, the treatment ϫ region, strain ϫ region or the treatment ϫ strain ϫ region interactions. The treatment ϫ strain interaction (F 5,197 ϭ 1.7, p Ͻ 1.2 ϫ 10
Ϫ1
) did not meet the 10 Ϫ2 threshold for significance; these data are presented in Figure 3 . As in the CPu, 0.1 mg/kg haloperidol induced marked increases (Ͼ 75%) in the number of Fosli neurons in both strains.
The shell of the NAc was divided into a medial and ventral component (Figure 1 ). Significant effects were detected only for treatment (F 5,197 ϭ 23, p Ͻ 10
Ϫ5
). The treatment ϫ strain interaction (F 5,197 ϭ 1.9, p Ͻ 10
Ϫ1
) did not meet the threshold for significance; these data are presented in Figure 3 . As in the core, the haloperidol effect was marked, approximately doubling the number of Fos-li neurons in both strains over the dose range of 0.3 to 3 mg/kg.
Ventral Pallidum, Globus Pallidus, and Subthalamic Nucleus
For the ventral pallidum (VP) significant effects were detected only for treatment (F 5,198 ϭ 26, p Ͻ 10
Ϫ5
). The treatment ϫ strain interaction (F 5,198 ϭ 2.6, p Ͻ 3 ϫ 10 Ϫ2 ) did not meet the 10 Ϫ2 threshold for significance. These data do however, suggest a trend to a greater effect in the D2 strain at the 1 and 3 mg/kg haloperidol doses (Figure 4) .
For the globus pallidus (GP) significant effects were detected for treatment (F 5,198 ϭ 82, p Ͻ 10
) and strain (F 1,198 ϭ 22, p Ͻ 10 Ϫ4 ) but not for the treatment ϫ strain interaction (F 5,198 ϭ 2.1 p Ͻ 6 ϫ 10 Ϫ2 ); these data are pre-sented in Figure 4 . On average, the number of Fos-li neurons in the D2 strain was 31% higher as compared to the B6 strain across all treatments. No significant effects were detected in the subthalamic nucleus (STh); these data are summarized in Table 1 .
Entopeduncular Nucleus, Substantia Nigra Zona Reticulata and Compacta, and Ventral Tegmental Area
The entopeduncular nucleus (EP) was divided into a lateral and medial component ( Figure 1) ; given the marked difference in the number of Fos-li neurons, the two components were analyzed separately. In the lateral EP, there was a significant effect for treatment (F 5,194 ϭ 88, p Ͻ 10 Ϫ5 ) but not for the treatment ϫ strain interaction (F 5,194 
). For the medial EP significant effects were detected for treatment (F 5,194 ϭ 120, p Ͻ 10 Ϫ5 ), strain (F 1,194 ϭ 132, p Ͻ 10
Ϫ5
) and the treatment ϫ strain interaction (F 5,197 ϭ 7.4, p Ͻ 10
Ϫ4
). These latter data are presented in Figure 5 and illustrate that over the dose range of 0.1 to 3 mg/kg haloperidol, the number of Fos-li neurons was significantly higher in the D2 strain. Representative images from this region are found in Figure 7b .
The substantia nigra zona reticulata (SNr) was divided into a lateral an medial component ( Figure 1 ). As shown in Table 1 , the lateral aspect contained few Fos-li neurons and these data were not analyzed further. For the medial SNr, significant effects were detected for treatment (F 5,194 ϭ 91, p Ͻ 10 Ϫ5 ), strain (F 1,194 ϭ 42, p Ͻ 10
Ϫ5
) and the treatment ϫ strain interaction (F 5,194 ϭ 11, p Ͻ 10
). As shown in Figure 5 , the D2 strain showed a significantly greater response in ventral SNZr at 1 and 3 mg/kg. Representative images are shown in Figure 7c .
For the substantia nigra zona compacta (SNc) significant effects were detected only for treatment (F 5,194 ϭ 19, p Ͻ 10
). The treatment ϫ strain interaction (F 5,194 ϭ 2.3, p Ͻ 5 ϫ 10 Ϫ2 ) was not significant. However, the data suggest a great number of Fos-li neurons in the B6 strain as compared to the D2 strain at 6 mg/kg haloperidol ( Figure 6 ).
For the ventral tegmental area (VTA) significant effects were detected for treatment (F 5,194 ϭ 47, p Ͻ 10 Ϫ5 ) and strain (F 1,194 ϭ 10, p Ͻ 10
Ϫ3
). The treatment ϫ strain interaction (F 5,194 ϭ 2.8, p Ͻ 2 ϫ 10 Ϫ2 ) did not meet the 10 Ϫ2 threshold for significance. However, the data suggest that over the dose range of 0.1 to 3 mg/kg haloperidol, the number of Fos-li neurons was higher in the D2 strain (Figure 6 ).
DISCUSSION
Previous studies from this laboratory have established that the D2 and B6 inbred mouse strains differ almost 10-fold in their sensitivity to haloperidol-induced catalepsy, a putative animal model of EPS (Kanes et al. 1993) . In contrast, we have recently observed that the D2 and B6 strains are equally sensitive to the haloperidol facilitation of prepulse inhibition (PPI) of the acoustic startle response (McCaughran et al. 1997) ; presumably, this increase in PPI results largely from haloperidol's effects on the mesolimbic dopamine system (see e.g., Swerdlow et al. 1994) . Further, the D2 and B6 strains are equally sensitive to the increase in PPI seen after the administration of the atypical neuroleptics, clozapine, and risperidone. These data led us to postulate that the D2 and B6 strains would differ in their Fos response to haloperidol in the same way that rats and nonhuman primates differ in their response to haloperidol and clozapine (e.g. Dragunow et al. 1990; Nguyen et al. 1992; Deutch and Cameron 1992; Deutch et al. 1996; Robertson et al. 1994 ). Thus, it was expected that compared to the B6 strain, the D2 strain would show a greater increase in the number of Fos-li neurons in the dorsolateral CPu after haloperidol treatment, but the strains would be equally sensitive to the effects of haloperidol in the NAc. The data in Figures 2 and 7a , b, and c clearly establish that the D2 strain does not show a greater Fos response in the dorsolateral CPu; in fact the data suggest that the B6 strain which has a higher density of D 2 dopamine receptors in the CPu (Kanes et al. 1993; Erwin et al. 1993 ) is moderately but significantly more sensitive to the effects of haloperidol. Interestingly, in the NAc there were no difference in the Fos response, even though D 2 receptor density is significantly higher in the B6 strain (Kanes et al. 1993; Erwin et al. 1993) . Overall, these data illustrate that the striatal Fos response to haloperidol in the B6 and D2 inbred strains does not predict the behavioral outcome (catalepsy). In preliminary studies of the BALB/cJ and LP/J strains, we have found similar results; these strains are the extreme phenotypes and differ more than 30-fold in their haloperidol ED 50s .
The alternative working hypothesis was that the D2 and B6 strains would differ at the output nuclei of the basal ganglia. The data in Figure 5 support this hypothesis. The D2 strain showed a greater Fos response in both the EP and SNr. The effect in the EP was detected over a wide range of haloperidol doses (0.1 to 3 mg/kg) and in the SNr at 1 and 3 mg/kg of haloperidol. If the Fos positive neurons in the EP and SNr are the GABA efferents which project to the thalamus, these data may explain the differential behavioral response. These data support and extend the observations of Wirtshafter and Asin (1995) who noted that in the rat, both haloperidol (0.5-8 mg/kg) and metoclopramide (6.25-50 mg/kg) cause a dose dependent increase in the number of Fos-li neurons in the rostral portion of the EP and the medial aspect of the SNr. The regions sampled in the present study were similar to those used by Wirtshafter and 
